Amylyx Pharmaceuticals, Inc.
$34.74
-2.44 (-6.56%)
Price as of Aug 28, 2026 market close
Performance
- 1 Month
- +67.4%
- 3 Months
- +142.1%
- YTD
- +187.6%
- 1 Year
- +267.6%
Price return, based on split- and dividend-adjusted closing prices.
Risk
- Volatility 1-year annualized
- 88.4%
- Largest decline max drawdown, since Aug 2025
- -30.6%
- Risk-adjusted return Sharpe ratio, 1-year
- 1.85
Own AMLX?
See how AMLX contributes to your portfolio's return, allocation, and risk.
7-day free trial, then $9/month.